Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failure
- 1 December 2002
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 86 (2-3) , 143-149
- https://doi.org/10.1016/s0167-5273(02)00409-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failurePublished by Elsevier ,2010
- Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care settingJournal of the American College of Cardiology, 2001
- A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot studyJournal of the American College of Cardiology, 2001
- Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarctionHeart, 1999
- Risk stratification in chronic heart failurePublished by Oxford University Press (OUP) ,1998
- Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practiceHeart, 1997
- Value of natriuretic peptides in assessment of patients with possible new heart failure in primary careThe Lancet, 1997
- The epidemiology of heart failureEuropean Heart Journal, 1997
- Comparison between New York Heart Association Classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1992
- Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).Circulation, 1990